XORTX Therapeutics Inc Cash Flow Quality Index

Latest as of December 2024: -7.23x

XORTX Therapeutics Inc cash flow quality index. XORTX Therapeutics Inc (XRTX) has a Cash Flow Quality Index of -7.23x as of December 2024. Operating cash flow of CA$-886.41K is below net income of CA$122.53K, suggesting accrual-heavy earnings not yet converted to cash. See XRTX financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-7.23x

Operating CF / Net Income

Operating Cash Flow

CA$-886.41K

CAD

Net Income

CA$122.53K

CAD

Data as of

Dec 2024

Most recent filing

XORTX Therapeutics Inc Cash Flow Quality Index by Year (None–None)

XORTX Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for XORTX Therapeutics Inc. For the full cash flow conversion analysis, see XRTX operating cash flow.

Year	Quality Index	Operating CF (CAD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.